Risk of switching to angiotensin-II receptor blocker therapy in people with asthma who initiate ACE inhibitor therapy compared to the general population: a retrospective cohort study

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/35084
• EU PAS number:
  EUPAS35083
• Study ID:
  35084
• Official title and acronym:
  Risk of switching to angiotensin-II receptor blocker therapy in people with asthma who initiate ACE inhibitor therapy compared to the general population: a retrospective cohort study
• DARWIN EU® study:
  No
• Study countries:
  United Kingdom
• Study description:
  UK population-based retrospective observational cohort study
• Study status:
  Ongoing

Research institutions and networks

Institutions

University of Dundee

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 09/05/2016

Actual: 18/10/2016

Study start date

Planned: 23/08/2016

Actual: 11/04/2017

Data analysis start date

Planned: 13/02/2018

Actual: 11/12/2018

Date of final study report

Planned: 16/06/2020

Sources of funding

Non-for-profit organisation (e.g. charity)

More details on funding

Tenovus Scotland

Study protocol

Initial protocol

EUPAS35083-35082

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable